SIRT3 Protein - Mitochondrial Sirtuin

Migration, Crosslink

📖

SIRT3 Protein - Mitochondrial Sirtuin

active

wiki page Created: 2026-04-02T07:19:06 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-sirt3-protein

📖 Wiki Page

protein1426 wordssynced 2026-04-02

SIRT3 Protein - Mitochondrial Sirtuin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SIRT3 Protein - Mitochondrial Sirtuin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWU1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~44 kDa (full-length), ~28 kDa (processed mature form)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondria matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Sirtuin family (Class I)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain, heart, liver, kidney; moderate in skeletal muscle</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>Honokiol</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT1720</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT2104</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NMN (Nicotinamide mononucleotide)</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NR (Nicotinamide riboside)</td>
</tr>
<tr>
<td class="label">Indirect activation</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">

...

SIRT3 Protein - Mitochondrial Sirtuin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SIRT3 Protein - Mitochondrial Sirtuin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWU1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~44 kDa (full-length), ~28 kDa (processed mature form)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondria matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Sirtuin family (Class I)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain, heart, liver, kidney; moderate in skeletal muscle</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>Honokiol</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT1720</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT2104</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NMN (Nicotinamide mononucleotide)</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NR (Nicotinamide riboside)</td>
</tr>
<tr>
<td class="label">Indirect activation</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-seaad-v4-5a7a4079" style="color:#ce93d8" title="Score: 0.68">SIRT3-Mediated Mitochondrial Deacetylati...</a><br><a href="/hypothesis/h-0e614ae4" style="color:#ce93d8" title="Score: 0.45">Mitochondrial-Nuclear Epigenetic Cross-T...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">725 edges</a></td>
</tr>
</table>

Overview

SIRT3 (Sirtuin 3) is a NAD⁺-dependent deacetylase enzyme localized primarily to the mitochondrial matrix, where it serves as the primary mitochondrial protein deacetylase. SIRT3 plays critical roles in regulating cellular metabolism, oxidative stress responses, and mitochondrial quality control—all processes fundamental to neuronal survival in neurodegenerative diseases. This page provides comprehensive information about SIRT3's structure, function, and significance in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions. [@lombard2020]

Introduction

Sirtuins (SIRT1-7) are a highly conserved family of NAD⁺-dependent deacetylases that regulate cellular homeostasis through protein deacetylation. SIRT3 is uniquely positioned as the major mitochondrial deacetylase, with broad substrate specificity targeting over 20% of mitochondrial proteins. In the brain, SIRT3 expression is highest in regions with high metabolic demand, including the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and substantia nigra—areas particularly vulnerable to neurodegeneration. [@hirschey2010]

Protein Overview

Structure

SIRT3 protein structure consists of several key domains:

Primary Structure

N-terminal mitochondrial targeting sequence (MTS): First ~25 amino acids that direct import into mitochondria
Catalytic core domain: Rossmann-fold structure (~275 amino acids)
NAD⁺-binding pocket: Highly conserved sirtuin signature motif (VTN/VGAGV)
Acetyl-lysine binding pocket: Substrate recognition region

Tertiary Structure

The catalytic domain adopts a Rossmann-fold architecture common to NAD⁺-binding enzymes, with a large cavity allowing access to acetylated lysine residues on substrate proteins. The structure has been solved by X-ray crystallography (PDB: 3GLS, 4JZR).

Post-Translational Processing

SIRT3 is synthesized as a full-length precursor (~44 kDa) and proteolytically processed in mitochondria by mitochondrial processing peptidase to generate the mature, active form (~28 kDa).

Normal Function

Enzymatic Activity

SIRT3 exhibits multiple enzymatic activities:

Deacetylation: Primary activity; removes acetyl groups from lysine residues
Demalonylation: Removes malonyl groups (recently discovered)
Desuccinylation: Removes succinyl groups
ADP-ribosylation: Lower activity (controversial)

Metabolic Regulation

SIRT3 deacetylates and activates numerous metabolic enzymes:

IDH2 (Isocitrate dehydrogenase 2): Enhances NADP⁺/NADPH production, supporting antioxidant defenses
SDH (Succinate dehydrogenase): Optimizes Complex II activity in ETC
GDH (Glutamate dehydrogenase): Regulates amino acid metabolism
LCAD (Long-chain acyl-CoA dehydrogenase): Fatty acid β-oxidation
HMGCS2 (Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2): Ketogenesis

Antioxidant Defense

SIRT3 is a critical regulator of mitochondrial [ROS](/entities/reactive-oxygen-species) detoxification:

SOD2 (Superoxide dismutase 2): Deacetylates SOD2 at Lys-122, dramatically increasing its activity
OGG1 (8-oxoguanine DNA glycosylase): Enhances DNA repair capacity
IDH2: Increases NADPH production for glutathione reductase

Mitochondrial Quality Control

Complex I: Deacetylates NDUFA9, optimizing NADH oxidation
Complex III: Regulates cytochrome c oxidase activity
TFAM: Influences mitochondrial DNA transcription

Additional Functions

[Apoptosis](/entities/apoptosis) regulation: Deacetylates p53, modulating pro-apoptotic signaling
Calcium homeostasis: Influences mitochondrial calcium buffering
Lipid metabolism: Regulates fatty acid oxidation and ketogenesis

Role in Neurodegeneration

Alzheimer's Disease

SIRT3 provides multifaceted protection in AD:

[Amyloid-Beta](/proteins/amyloid-beta) Toxicity

SIRT3 deacetylates SOD2, enhancing clearance of ROS generated by Aβ accumulation
Protects against Aβ-induced mitochondrial dysfunction in hippocampal [neurons](/entities/neurons)
SIRT3 activation reduces Aβ-induced apoptosis in neuronal cultures

Mitochondrial Dysfunction

Maintains mitochondrial membrane potential and ATP production
Preserves electron transport chain integrity in neurons
Protects against Aβ-induced Complex I and III dysfunction

Neuroinflammation

Reduces [NLRP3](/entities/nlrp3-inflammasome) inflammasome activation via deacetylation
Modulates microglial activation and cytokine production

Clinical Evidence

SIRT3 expression is significantly reduced in AD brain (temporal cortex, hippocampus)
Lower SIRT3 levels correlate with cognitive decline severity
SIRT3 polymorphisms associated with AD risk in some populations

Therapeutic Potential

SIRT3 activators (honokiol, SRT1720) show promise in AD mouse models
NAD⁺ boosters (NMN, NR) increase SIRT3 activity indirectly
Overexpression of SIRT3 reduces Aβ pathology in [APP](/entities/app-protein)/PS1 mice

Parkinson's Disease

SIRT3 is particularly important for dopaminergic neuron survival:

Mitochondrial Protection

Maintains Complex I activity, critical for dopaminergic neurons
Protects against 6-OHDA and MPTP-induced toxicity
Preserves mitochondrial membrane potential in substantia nigra neurons

Oxidative Stress

SOD2 deacetylation provides crucial ROS detoxification
Protects against iron-induced oxidative damage (relevant to PD iron accumulation)
Maintains glutathione levels in dopaminergic cells

[α-Synuclein](/proteins/alpha-synuclein) Pathology

SIRT3 protects against α-synuclein-induced mitochondrial dysfunction
Reduces α-synuclein aggregation in cellular models
May influence prion-like propagation of α-synuclein

Therapeutic Approaches

SIRT3 activators protect dopaminergic neurons in MPTP models
NAD⁺ supplementation increases SIRT3 activity
Honokiol administration reduces dopaminergic loss in Parkin-deficient mice

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Vulnerability

Motor neurons have high metabolic demands and mitochondrial content
SIRT3 protects against oxidative stress in motor neurons
SIRT3 levels reduced in ALS models and patient tissue

Mitochondrial Dysfunction

Maintains mitochondrial ATP production
Protects against SOD1 mutation-induced mitochondrial damage
Preserves axonal mitochondrial transport

Therapeutic Potential

SIRT3 activation protects motor neurons in SOD1-G93A mice
NAD⁺ boosters show benefit in ALS models
SIRT3-5-Fluorouracil interaction under investigation

Other Neurodegenerative Conditions

Huntington's Disease

Protects against mutant [huntingtin](/proteins/huntingtin-protein)-induced mitochondrial dysfunction
SIRT3 activators improve motor performance in HD models
Modulates BDNF signaling

Multiple System Atrophy (MSA)

May protect against oligodendrocyte dysfunction
Relevant to autonomic nervous system degeneration

Friedreich's Ataxia

SIRT3 targets frataxin-deficient mitochondria
Potential therapeutic target

Mechanism of Action

Signaling Pathways

Aβ / α-Syn / Mutant Proteins
↓
Mitochondrial Damage
↓
ROS Production ↑
↓
SIRT3 Activation (NAD⁺-dependent)
↓
SOD2 Deacetylation → Activation
↓
ROS Clearance ↑
↓
Mitochondrial Function Preservation
↓
Neuronal Survival ↑

Key Molecular Interactions

NAD⁺ binding: Required for deacetylase activity; cellular NAD⁺ levels directly regulate SIRT3
Acetyl-CoA: High mitochondrial acetyl-CoA can inhibit SIRT3 activity
p53: Deacetylation modulates apoptosis pathway
FOXO3a: Deacetylation enhances antioxidant gene expression
PGC-1α: Indirect regulation of mitochondrial biogenesis

Therapeutic Targeting

Biomarkers

SIRT3 as a Biomarker

Blood/CSF levels: Can be measured via ELISA
Activity assays: Functional deacetylation measurements
Clinical correlation: Levels correlate with disease severity in some studies

Diagnostic Potential

Not yet validated for clinical diagnosis
Research use in distinguishing disease subtypes
Potential for monitoring treatment response

Research Challenges

Specific activators: Lack of highly SIRT3-selective compounds

[Blood-brain barrier](/entities/blood-brain-barrier): NAD⁺ boosters have limited CNS penetration

Activity measurement: Difficult to assess SIRT3 activity in vivo

Isoform specificity: SIRT3 vs. other sirtuins

Key Publications

[Hirschey MD, et al. SIRT3 regulates mitochondrial protein acetylation and metabolism. Nature. 2010;464(7285):121-125](https://pubmed.ncbi.nlm.nih.gov/20203689/)

[Liu L, et al. SIRT3 protects dopaminergic neurons from mitochondrial dysfunction and oxidative stress in Parkinson's disease. Parkinsonism Relat Disord. 2019;69:28-34](https://pubmed.ncbi.nlm.nih.gov/31257023/)

[Kincaid B, Bossy-Wetzel E. SIRT3: A neural target for modulating oxidative stress and mitochondrial dynamics in neurodegenerative disease. Antioxid Redox Signal. 2022;37(4-6):287-304](https://pubmed.ncbi.nlm.nih.gov/35188856/)

[Lee J, et al. SIRT3 deacetylates SOD2 to facilitate mitophagy in the protection against Aβ-induced neuronal death. J Neurochem. 2018;145(5):372-382](https://pubmed.ncbi.nlm.nih.gov/29314012/)

[Han Y, et al. Sirt3 deficiency exacerbates neuronal damage after traumatic brain injury through enhancing oxidative stress. J Neurotrauma. 2019;36(2):227-239](https://pubmed.ncbi.nlm.nih.gov/29929414/)

[Wang F, et al. SIRT3 activation attenuates neuroinflammation and oxidative stress in Alzheimer's disease. Front Cell Neurosci. 2021;15:685158](https://pubmed.ncbi.nlm.nih.gov/34262461/)

[Song W, et al. Mitochondrial SIRT3 mediates oxidative stress-induced apoptosis in experimental model of Parkinson's disease. Neurochem Res. 2020;45(11):2604-2617](https://pubmed.ncbi.nlm.nih.gov/32860682/)

[Cheng Y, et al. Sirt3 attenuates amyotrophic lateral sclerosis by regulating mitochondrial function. CNS Neurosci Ther. 2021;27(12):1523-1534](https://pubmed.ncbi.nlm.nih.gov/34523251/)

Background

The study of Sirt3 Protein Mitochondrial Sirtuin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway & Interaction Diagram

Interactive diagram showing SIRT3 key relationships in the SciDEX knowledge graph (15 connections shown).

Mermaid diagram (expand to render)

slug	proteins-sirt3-protein
kg_node_id	SIRT3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6f3e217d96ed
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-sirt3-protein'}
_schema_version	1

📗 Cite This Artifact

SIRT3 Protein - Mitochondrial Sirtuin

SIRT3 Protein - Mitochondrial Sirtuin

SIRT3 Protein - Mitochondrial Sirtuin

Overview

Introduction

Protein Overview

Structure

Primary Structure

Tertiary Structure

Post-Translational Processing

Normal Function

Enzymatic Activity

Metabolic Regulation

Antioxidant Defense

Mitochondrial Quality Control

Additional Functions

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Other Neurodegenerative Conditions

Mechanism of Action

Signaling Pathways

Key Molecular Interactions

Therapeutic Targeting

Biomarkers

SIRT3 as a Biomarker

Diagnostic Potential

Research Challenges

Key Publications

Background

Pathway & Interaction Diagram

See Also

💬 Discussion